Opioid Early Career Scholar Program⁠ ⁠ An intensive multi-day opioid REMS initiative in Pain Management⁠ ⁠ Register Today⁠ ⁠ Early Bird Deadline: February 14th⁠ March 15-16, 2025⁠ Wyndham Garden Lake Buena Vista ⁠ Buena Vista, FL⁠ ⁠ CME Outfitters #health #wellness

Do you have 🔬 or a review on #NF1 in prep? Tell us about it! Jay Pundavela PhD Kyle Williams, PhD & I are thrilled to Guest Edit Current Oncology's Special issue on #NF1! Plz share and reach out re: potential submissions! tiny.cc/NF1 Children's Tumor Fdn Neurofibromatosis Therapeutic Acceleration Program Neurofibromatosis Young Investigators Forum

TOMORROW! ⏳ MEK Inhibitors in Neurofibromatosis Type 1 🗓️ Date: May 8, 2025 🕛 Time: 12:15 PM EST 📍Kentucky International Convention Center | Room: Ballroom B | Louisville, KY 🔗 ce.ceconcepts.com/MM-153 #NF1PN #OncologyEducation #HCPs #NF1Care Angela Hirbe Amy Armstrong

Today’s the Day! 🎉 Join us TODAY at 12:15 PM EST -Live symposium on MEK inhibitors in NF1-PN management. 🥼 Angela Hirbe Amy Armstrong 📍 Kentucky International Convention Center | Room: Ballroom B | Louisville, KY 🔗 ce.ceconcepts.com/MM-153 #NF1 #OncologyLive #HCPs #NF1PNCare

Follow us to our session on MEK Inhibitors in Neurofibromatosis Type 1 at the KY Int'l Conv. Ctr, Ballroom B at 12:15 TODAY! ce.ceconcepts.com/MM-153 Angela Hirbe Amy Armstrong

We’re Live in 1 hour—Join Us! 🔴Tune in for MEK inhibitors are changing the game for NF1-PN treatment! 🥼 Angela Hirbe Amy Armstrong 📍 Kentucky International Convention Center | Room: Ballroom B | Louisville, KY 🔗 ce.ceconcepts.com/MM-153 #NF1Treatment #HCPsLive #NF1Care

We’re Live in 1 hour—Join Us! 🔴 We’re officially LIVE here at CEC Oncology—tune in now to explore how MEK inhibitors are changing the game for NF1-PN treatment! 🥼 Angela Hirbe Amy Armstrong 📍 Kentucky International Convention Center | Room: Ballroom B | Louisville, KY 🔗

Getting ready for a dynamic discussion on MEK Inhibitors in Neurofibromatosis Type 1 at the KY Int'l Conv. Ctr, Ballroom B at 12:15 TODAY! ce.ceconcepts.com/MM-153 Can't make it live? Join the livestream: ce.ceconcepts.com/MMS153livestre… Amy Armstrong Angela Hirbe

🔴STARTING IN 15 MINUTES MEK Inhibitors in Neurofibromatosis Type 1 🥼 Angela Hirbe Amy Armstrong 📍 Kentucky International Convention Center | Room: Ballroom B | Louisville, KY 🔗 ce.ceconcepts.com/MM-153 #NF1Treatment #HCPsLive #OncologyUpdates #NF1Care

"We shouldn't underestimate the impact of mild developmental delays on the well-being of the child." -Dr. Angela Hirbe

"Not everyone with a PN needs treatment.  Observation is OK in the absence of morbidity, but shared decision making with the parents is important to discuss the pros and cons of treatment." - Dr. Angela Hirbe, live from the CEC Oncology session on MEK Inhibitors in

"The initial referral to the neurologist was critical." Sarah Neale, Patient Advocate, speaking at a CEC Oncology symposium session on MEK Inhibitors in Neurofibromatosis Type 1: Latest Advances and Real-world Applications in NF1-PN Management ce.ceconcepts.com/MMS153livestre………

"Patients with NF1-PNs on MEK inhibitors need to have ongoing ocular and cardiac monitoring." - Dr. Amy Armstrong

"Pain tends to be the greatest indication for MEKi treatment in adults." - Dr. Angela Hirbe

"Current data suggests that long-term ejection fraction decrease reverses after coming off the MEK inhibitor and doesn't preclude future treatments." - Dr. Angela Hirbe

"Readiness to transition to adult care is very individualized.  Some patients are ready early, others, particularly with cognitive deficits, may require an extended transition period." - Dr. Amy Armstrong

Thank You for Attending! 🙌 A huge THANK YOU to all the HCPs & oncology experts who joined us LIVE for today’s symposium on NF1-PN management & MEK inhibitors! ➡️ What was your #1 takeaway from today’s event? Let us know! 👇 Angela Hirbe Amy Armstrong

🚨 Calling all #Neurofibromatosis researchers! The 2025 NF Young Investigators’ Forum is accepting abstracts! 🧠 Career development, expert mentorship, & patient voices await. 📍 Dec 4–5 | Baltimore 🔗 Submit: info.ceconcepts.com/nfyif-001 #NFResearch #YoungInvestigators #MedEd

Are you a junior faculty, fellow, or PhD student advancing #NF research? Your work deserves a spotlight. Submit your abstract to the 2025 NFYIF by 9/8! 🗓️ Dec 4–5 | Baltimore 🔗info.ceconcepts.com/nfyif-001 #Neurofibromatosis #NFResearch #EarlyCareer Children's Tumor Fdn

Grow your network, present your work, and meet the #Neurofibromatosis community. 🎤 Abstracts now open for #NFYIF 2025 Deadline: Sept 8 🔗 info.ceconcepts.com/nfyif-001 #YoungInvestigators #MedTwitter #NFResearch Children's Tumor Fdn